Importantly, these agents, including nitrofen (38), inhibit retinal dehydrogenase-2 (RALDH-2), a key enzyme for the production of retinoic acid, suggesting that disruption of the retinoid signaling pathway (including vitamin A deficiency) contributes to CDH pathogenesis. The gene discussed is ALDH1A2; the disease is congenital diaphragmatic hernia.